Cannabis Law Report

AUGUST 29, 2022

Founder, CEO, President of Somai Pharmaceuticals. THE COMPLIANCE DISPENSARY. Song: Beat Your Heart Out by The Distillers. Supplementary Info. AllayConsulting.com. INTERVIEW 3. Michael Sassano. Song: Wicked Game by Chris Isaac. INTERVIEW 4. With AMY MCDOUGAL ATTORNEY AND FOUNDER OF CLEARESOURCES. Supplementary Information.

Pharmaceutical 52

Pharmaceutical Programs Compliance Compliance 52

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Accelerate Freia’s growth and expansion.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

NOVEMBER 7, 2019

31 that it had hired Beth Burk as interim chief legal and compliance officer. She had most recently spent four years as global chief compliance officer at professional services firm Aon Corp., I am thrilled to join the GTI team and to lead the company’s best-in-class compliance and governance practices,” Burk said in a statement.

Compliance 45

Compliance Compliance Pharmaceutical Legalization 45

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., Objective of the Agreement. million CAD.

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Cannabis Law Report

JULY 5, 2021

directly to authorities in order to maintain compliance. In order to be approved, the ERP must be accepted by local regulatory authorities for. accounting. This is important because the system will communicate cannabis financing details. All documentation that goes with any. operations running smoothly.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

Canna Law Blog

JANUARY 11, 2023

On January 20, 2023, the Dangerous Products and Services and Healthcare and Medicines Google Ads policies will allow for the promotion of “FDA-approved pharmaceuticals containing cannabidiol (CBD) and topical, hemp-derived CBD products with THC content of 0.3% Google states that in the U.S., Google states that in the U.S.,

Policy 68

Policy CBD Supply Chain Compliance 68

Cannabis Law Report

AUGUST 7, 2021

We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. Team leadership : mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously. Position Requirements.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

SEPTEMBER 10, 2021

1 producer of pharmaceutical-grade cannabis nutrients since 1999, creating an intuitive line of products trusted by growers all over the world. Ensure compliance with laws, regulations, and policies. JUNIOR COUNSEL. West Hollywood, CA. Advanced Nutrients has been the No. RESPONSIBILITIES. Review, edit, and draft contracts. 5PuPSSCAUb.

Compliance 98

Compliance Compliance Safety Policy 98

Cannabis Law Report

SEPTEMBER 26, 2021

JOB DESCRIPTION: Prepare, coordinate and supervise regulatory submissions for NHPs, pharmaceuticals and cosmetic products. Review product conformance and assure compliance. Working closely with the regulatory body – Health Canada to address inquiries related to compliance. REQUIREMENTS: B.Sc REQUIREMENTS: B.Sc

Compliance 52

Compliance Compliance Research and Development Pharmaceutical 52

Cannabis Law Report

AUGUST 27, 2021

The pilot program includes three types of high-quality pharmaceutical-grade dried flower medical cannabis, including Aurora 20/1 XPE (high-THC dried flower), Aurora 8/8 XPE (THC:CBD balanced dried flower), and Aurora 1/12 XPE (high-CBD dried flower). ”

Patients 105

Patients Programs Pharmaceutical Compliance 105

Cannabis Law Report

FEBRUARY 5, 2022

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team. ABOUT i-PHARM CONSULTING.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 26, 2021

Reporting directly to the Manager, Regulatory Affairs, the Regulatory Affairs Associate – Compliance is responsible for strategy and life-cycle management of all cannabis license activities and lifecycle management across Aleafia sites. They are responsible for continuous improvement in the compliance space across Aleafia sites.

Environment 52

Environment Compliance Compliance Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team. ABOUT i-PHARM CONSULTING.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

JUNE 17, 2021

NASDAQ: CLVR) said it has entered into an active pharmaceutical ingredient supply agreement with CBD Life Holding SAPI de CV, an emerging leader in the Mexican cannabis industry which offers a line of CBD Wellness and consumer products and medical cannabis products which are under development. Clever Leaves Holdings Inc.

CBD 111

CBD Pharmaceutical Compliance Compliance 111

Cannabis Law Report

FEBRUARY 24, 2020

AusCann Group Holdings Limited told the ASX the agreement with Clifford Hallam Healthcare (CH2) to store and distribute AusCann’s pharmaceutical products was cost effective and extended AusCann’s distribution network in Australia.

Medicine 66

Medicine Pharmaceutical Compliance Compliance 66

Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. “It also creates new opportunities for researchers, entrepreneurs, investors and pharmaceutical companies.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

AUGUST 29, 2021

The export to Brazil also confirms the regulatory pathway and acts as a proof of concept in the largest market in South America where we aim to establish long-lasting supply relationships with our Brazilian pharmaceutical partners.”. 1 Source: Passport, Euromonitor International, Cannabis in Latin America, July 2021.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

SEPTEMBER 1, 2021

Perform regulatory impact assessment of CMC relevant changes to ensure continuous compliance with applicable regulations. Perform internal departmental regulatory compliance audits to facilitate sustained conformance. Review product labels or other required documentation to ensure compliance with International requirements.

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

Cannabis Law Report

FEBRUARY 8, 2022

07, 2022 — Allied Corp. (“Allied” or the “Company”) ( OTCQB: ALID ) is pleased to announce the signing of a forward purchase agreement with a pharmaceutical partner out of Australia. This has included supplying small medical devices, consumable and pharmaceutical needs (on and off continent).

Pharmaceutical 52

Pharmaceutical Compliance Compliance Medicine 52

Cannabis Law Report

APRIL 29, 2022

Our local team’s expertise and experience in the pharmaceutical and medical cannabis industries will enable Clever Leaves Germany to act as a reliable partner that meets the high-quality standards and regulations of the German market and of our clients,” he stated. “As BOCA RATON, Fla.

Pharmaceutical 52

Pharmaceutical Compliance Compliance Cannabinoids 52

Cannabis Law Report

DECEMBER 15, 2021

Pharmaceuticals & Medical Devices. With the support of the Regulatory Affairs Manager, manage and lead the range of products supplied by Cann to ensure compliance with all internal and external regulatory requirements for Australia. Educated to a degree level in pharmaceutical, medical or science related subjects.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

DECEMBER 15, 2021

for authorized research purposes at competitive prices, and aims to help ease supply chain issues currently facing hundreds of pharmaceutical companies, research institutions, and nonprofits across the United States of American that cannot find psilocybin for authorized research purposes at an affordable price. About Mycrodose Therapeutics.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 1, 2021

“The injection of both financial and human capital, combined with GenCanna’s formidable CBD ingredient extraction and refinement sciences, and its sterling compliance track record, will now greatly facilitate the expansion and completion of several key channel strategies and market growth initiatives currently within the CBD Capital pipeline.”.

CBD 102

CBD Supply Chain Compliance Compliance 102

Cannabis Law Report

MARCH 6, 2022

Michael Sassano CEO and Chairman of the Board Somai Pharmaceuticals. Michael who has been writing regular articles for cannabis law jnl on all things international compliance and GMP over the past year talks to Heather about the cannabis global market, GMP, EU market and US influence. INTERVIEW 2. Michael Sassano.

Pharmaceutical 52

Pharmaceutical Compliance Compliance Treatment 52

Cannabis Law Report

MARCH 9, 2022

Pharmaceuticals & Medical Devices. With the support of the Regulatory Affairs Manager, manage and lead the range of products supplied by Cann to ensure compliance with all internal and external regulatory requirements for Australia. Educated to a degree level in pharmaceutical, medical or science related subjects.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

MJ Business Attorneys

JUNE 29, 2018

So for now, we wait in anticipation for the DEA to commence proceedings to determine how to amend the scheduling of CBD under the CSA in a way that will allow for Epidiolex to be prescribed by health care providers and dispensed by pharmaceutical companies appropriately and legally.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

JULY 29, 2021

With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

NOVEMBER 23, 2021

will be in compliance with all applicable Health Canada regulations. and is an active contributor in the pharmaceutical, nutraceutical and psychedelic wellness industries. Our Management and Advisory team are industry veterans in the pharmaceutical & consumer goods industries. On Behalf of The Board of Directors.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

JUNE 4, 2022

Eastern Cape cannabis producer, Sweetwaters, has produced a ton of 26% THC flower to be exported to an Australian pharmaceutical client. Sweetwaters has an offtake agreement in place with an Australian pharmaceutical client and Labat has now facilitated the export of the current yield to the Queensland-based buyer”.

THC 52

THC Pharmaceutical Research and Development Cultivation 52

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

SEPTEMBER 29, 2022

The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd. If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Cannabis Law Report

NOVEMBER 19, 2021

We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Contract control : review and interpret corporate contracts, non-disclosure agreements, data processing agreements, fiscal sponsorship agreements, and other legal compliance documents.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

MARCH 15, 2023

The FT writes Update to Home Office licence will allow London-listed pharmaceuticals group to pursue supply deals Celadon Pharmaceuticals has become the first UK-based medical cannabis manufacturer to be granted a Home Office licence to sell its products in the UK since government reforms opened up the industry in 2018.

Pharmaceutical 52

Pharmaceutical Cannabis Compliance Compliance 52

Cannabis Law Report

JUNE 6, 2022

As a trusted leader in evidence-based medication advisory resources for pharmacists and other clinicians, TRC Healthcare is filling that knowledge gap by partnering with the University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences. About the Skaggs School of Pharmacy and Pharmaceutical Sciences.

Education 52

Education Research and Development Pharmaceutical Programs 52

Cannabis Law Report

JANUARY 23, 2022

Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. a business management and regulatory consulting firm, she led numerous Licensed Producers in achieving regulatory compliance and streamlining business operations. Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

Cannabis Law Report

NOVEMBER 21, 2021

Provide technical support and ensure compliance during the development and approval of products for all markets. Manage Health Canada (and other government agencies) reporting requirements and overseeing licence maintenance, compliance and renewal. Conduct risk assessments and recommendations for various regulatory scenarios.

Research and Development 52

Research and Development Compliance Compliance Pharmaceutical 52

Cannabis Law Report

JUNE 29, 2021

” “At BRC, we are focused on developing federally compliant active pharmaceutical ingredients for federally compliant researchers examining the therapeutic effects of cannabis,” George Hodgin, CEO of Biopharmaceutical Research Company. Learn more at Segra International or by viewing the 2021 Cultivar and Services Catalogue.

Research and Development 102

Research and Development DEA Supply Chain Pharmaceutical 102